187 related articles for article (PubMed ID: 3265656)
1. The IgG antibody reactivity of sera from patients with active chronic hepatitis to a crude liver antigen and liver specific protein (LSP): analysis by ELISA and immunoblotting.
Sundin U; Heigl Z; Sundqvist KG
Clin Exp Immunol; 1988 Nov; 74(2):276-82. PubMed ID: 3265656
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to liver cell membrane antigens in chronic active hepatitis (CAH). III. Partial characterization of the liver cell membrane antigens and comparison of reactivities in sera from patients with various liver diseases.
Frazer IH; Mackay IR
Clin Exp Immunol; 1984 Aug; 57(2):429-37. PubMed ID: 6432384
[TBL] [Abstract][Full Text] [Related]
3. Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis.
Stechemesser E; Klein R; Berg PA
Hepatology; 1993 Jul; 18(1):1-9. PubMed ID: 8325600
[TBL] [Abstract][Full Text] [Related]
4. Incidence of antibodies against rabbit liver specific lipoprotein (RLSP) in chronic active hepatitis.
Ortona L; Laghi V; Tamburrini E; Troncone L; Bonifazi N; Nervo P; Cauda R
Clin Exp Immunol; 1983 May; 52(2):437-40. PubMed ID: 6861379
[TBL] [Abstract][Full Text] [Related]
5. Antibodies against human liver-specific protein (LSP) in acute and chronic viral hepatitis types A, B and non-A, non-B.
Meliconi R; Baraldini M; Stefanini GF; Facchini A; Miglio F; Bortolotti F; Alberti A; Realdi G; Amoroso P
Clin Exp Immunol; 1981 Nov; 46(2):382-90. PubMed ID: 6802539
[TBL] [Abstract][Full Text] [Related]
6. Occurrence and significance of IgG liver membrane autoantibodies (LMA) in chronic liver diseases of different aetiology.
Meliconi R; Stancari MV; Garagnani M; Baraldini M; Stefanini GF; Miglio F; Gasbarrini G
Clin Exp Immunol; 1983 Mar; 51(3):565-71. PubMed ID: 6342885
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to liver membrane antigens in chronic active hepatitis (CAH). II. Specificity for autoimmune CAH.
Frazer IH; Kronborg IJ; Mackay IR
Clin Exp Immunol; 1983 Oct; 54(1):213-8. PubMed ID: 6616969
[TBL] [Abstract][Full Text] [Related]
8. Species cross-reactivity of anti-LSP antibodies in acute viral hepatitis.
Perperas A; McFarlane BM; McSorley CG; McFarlane IG; Williams R
J Clin Lab Immunol; 1986 Jan; 19(1):25-30. PubMed ID: 2422379
[TBL] [Abstract][Full Text] [Related]
9. Occurrence and significance of antibody to liver-specific membrane lipoprotein by double-antibody immunoprecipitation method in sera of patients with acute and chronic liver diseases.
Kakumu S; Arakawa Y; Goji H; Kashio T; Yata K
Gastroenterology; 1979 Apr; 76(4):665-72. PubMed ID: 105959
[TBL] [Abstract][Full Text] [Related]
10. LM-Ag and LSP--two different target antigens involved in the immunopathogenesis of chronic active hepatitis?
Meyer zum Büschenfelde KH; Manns M; Hütteroth TH; Hopf U; Arnold W
Clin Exp Immunol; 1979 Aug; 37(2):205-12. PubMed ID: 498582
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases.
Mulder AH; Horst G; Haagsma EB; Limburg PC; Kleibeuker JH; Kallenberg CG
Hepatology; 1993 Mar; 17(3):411-7. PubMed ID: 8444414
[TBL] [Abstract][Full Text] [Related]
12. "Anti-Ia reactivity in sera from patients with chronic active hepatitis (CAH)".
Levrero M; Barnaba V; Paroli M; Valesini G; Franco A; Laghi V; Cauda R; Balsano F
J Clin Lab Immunol; 1987 Oct; 24(2):63-8. PubMed ID: 2963916
[TBL] [Abstract][Full Text] [Related]
13. Immunological cross reactivity between Candida albicans and human tissue.
Vojdani A; Rahimian P; Kalhor H; Mordechai E
J Clin Lab Immunol; 1996; 48(1):1-15. PubMed ID: 10332630
[TBL] [Abstract][Full Text] [Related]
14. Antineutrophil cytoplasmic antibody in patients with antinuclear antibody-positive chronic hepatitis C.
Ohira H; Tojo J; Shinzawa J; Suzuki T; Miyata M; Nishimaki T; Kasukawa R
Fukushima J Med Sci; 1998 Dec; 44(2):83-92. PubMed ID: 10091380
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
16. Detection of antibodies to Chang liver cell in sera from patients with chronic liver diseases by 125I-labelled protein A binding assay and the effect of prednisolone and 6-mercaptopurine treatment on the level of the antibodies.
Inagaki Y; Morizane T; Matsumura S; Kawamura N; Watanabe T; Kumagai N; Nakamura T; Tsuchimoto K; Tsuchiya M
Clin Exp Immunol; 1984 Jul; 57(1):79-84. PubMed ID: 6540149
[TBL] [Abstract][Full Text] [Related]
17. The relationship between liver-specific lipoprotein and the hepatocyte plasma membrane.
Bartholomaeus WN; Swanson NR; Reed WD; O'Donoghue HL; Foti D; Papadimitriou JM
Immunology; 1987 Mar; 60(3):321-9. PubMed ID: 3032778
[TBL] [Abstract][Full Text] [Related]
18. Characterization of anti-liver kidney microsomal antibody in childhood autoimmune chronic active hepatitis: evidence for IgG1 subclass restriction, polyclonality and non cross-reactivity with hepatocyte surface antigens.
Peakman M; Lobo-Yeo A; Mieli-Vergani G; Davies ET; Mowat AP; Vergani D
Clin Exp Immunol; 1987 Sep; 69(3):543-9. PubMed ID: 3665184
[TBL] [Abstract][Full Text] [Related]
19. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
20. Antinuclear autoantibodies in chronic liver diseases.
Konikoff F; Isenberg DA; Barrison I; Theodor E; Shoenfeld Y
Hepatogastroenterology; 1989 Oct; 36(5):341-5. PubMed ID: 2620901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
